The global Cold Pain Therapy Market was valued at USD 850.43 million in 2016 and is projected to reach USD 1294.63 million by 2025, growing at a CAGR of 4.78% from 2017 to 2025.
Cold Pain Therapy Market is currently expanding due to number of factors such as neglecting the oral pain relieve medicines, increasing number of injuries and accidents rising the demand of pain free treatment.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing incidences of sport injuries
1.2 Growing demand for safer pain management modalities against oral drug therapy
1.3 Growing customer awareness due to promotional marketing
1.4 Increasing emphasis on exercise and gym activities to maintain good health
1.5 Rising regulatory barriers for oral pain medications
2. Market Restraints
2.1 Reimbursement Risks
2.2 Health hazards and risks
Market Segmentation:
1. Global Cold Pain Therapy Market, by Application:
1.1 Musculoskeletal Disorders
1.2 Post-Operative Therapy
1.3 Sport Medicines
1.4 Post-Trauma
1.5 Physical Therapy
2. Global Cold Pain Therapy Market, by Product:
2.1 OTC Based products
2.1.1 Pharmaceuticals
2.1.1.1 Gels, Ointments, and Creams
2.1.1.2 Sprays and Foams
2.1.1.3 Patches
2.1.1.4 Roll-On
2.1.2 Medical devices
2.1.2.1 Cold Packs
2.1.2.2 Cooling Towels, Compresses, Wraps, and Pads
2.2 Prescription Based
2.2.1 Motorized devices
2.2.2 Non-Motorized Devices
3. Global Cold Pain Therapy Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Hisamitsu Pharmaceutical Co., Inc.
2. Johnson & Johnson
3. Sanofi
4. Rohto Pharmaceutical Co., Ltd.
5. 3M Company
6. Medline Industries, Inc.
7. Beiersdorf AG
8. Breg, Inc.
9. Ã-ssur HF
10. DJO Finance LLC
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cold Pain Therapy Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL COLD PAIN THERAPY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL COLD PAIN THERAPY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL COLD PAIN THERAPY MARKET, BY APPLICATION
5.1 Overview
5.2 Musculoskeletal Disorders
5.3 Post-Operative Therapy
5.4 Sport Medicines
5.5 Post-Trauma
5.6 Physical Therapy
6 GLOBAL COLD PAIN THERAPY MARKET, BY PRODUCT
6.1 Overview
6.2 OTC Based products
6.2.1 Pharmaceuticals
6.2.1.1 Gels, Ointments, and Creams
6.2.1.2 Sprays and Foams
6.2.1.3 Patches
6.2.1.4 Roll-On
6.2.2 Medical devices
6.2.2.1 Cold Packs
6.2.2.2 Cooling Towels, Compresses, Wraps, and Pads
6.3 Prescription Based
6.3.1 Motorized devices
6.3.2 Non-Motorized Devices
7 GLOBAL COLD PAIN THERAPY MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
8 GLOBAL COLD PAIN THERAPY MARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 Hisamitsu Pharmaceutical Co., Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Johnson & Johnson
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Sanofi
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Rohto Pharmaceutical Co., Ltd.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 3M Company
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Medline Industries, Inc.
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Beiersdorf AG
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Breg, Inc.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Ã-ssur HF
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 DJO Finance LLC
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 Appendix
10.1 Related Reports